Zobrazeno 1 - 10
of 22
pro vyhledávání: '"Wongchenko MJ"'
Autor:
Dent RA; Division of Medical Oncology, National Cancer Centre Singapore, Singapore, Singapore.; Duke-NUS Medical School, Singapore, Singapore., Kim SB; Department of Oncology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea., Oliveira M; Medical Oncology Department, Vall d'Hebron University Hospital and Breast Cancer Group, Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain., Barrios C; Latin American Cooperative Oncology Group (LACOG), Oncoclínicas, Porto Alegre, Brazil., O'Shaughnessy J; Department of Medical Oncology, Baylor University Medical Center, Texas Oncology, US Oncology, Dallas, Texas., Isakoff SJ; Division of Hematology and Oncology, Massachusetts General Hospital, Boston, Massachusetts., Saji S; Department of Medical Oncology, Fukushima Medical University, Fukushima, Japan., Freitas-Junior R; Hospital Araujo Jorge, Goiania, Brazil., Philco M; Unidad de Investigación, Instituto de Oncología y Radioterapia, Clínica Ricardo Palma, San Isidro, Peru., Bondarenko I; Oncology and Medical Radiology Department, City Clinical Hospital No. 4, Dnipro, Ukraine., Lian Q; Biostatistics, Genentech, Inc., South San Francisco, California., Bradley D; Pharma Development, Roche Products Ltd., Welwyn Garden City, United Kingdom., Hinton H; Product Development Safety, F. Hoffmann-La Roche Ltd., Basel, Switzerland., Wongchenko MJ; Oncology Biomarker Development, Genentech, Inc., South San Francisco, California., Reilly SJ; Pharma Development, Roche Products Ltd., Welwyn Garden City, United Kingdom., Turner N; Breast Unit, The Royal Marsden NHS Foundation Trust, London, United Kingdom.; Breast Cancer Now Research Centre, The Institute of Cancer Research, London, United Kingdom.
Publikováno v:
Clinical cancer research : an official journal of the American Association for Cancer Research [Clin Cancer Res] 2024 Oct 01; Vol. 30 (19), pp. 4329-4338.
Autor:
Taraborrelli L; Department of Cancer Immunology, Genentech Inc., South San Francisco, USA., Şenbabaoğlu Y; Department of Oncology Bioinformatics, Genentech Inc., South San Francisco, USA., Wang L; Department of Cancer Immunology, Genentech Inc., South San Francisco, USA., Lim J; Department of Cancer Immunology, Genentech Inc., South San Francisco, USA., Blake K; Department of Cancer Immunology, Genentech Inc., South San Francisco, USA., Kljavin N; Department of Molecular Oncology, Genentech Inc., South San Francisco, USA., Gierke S; Center for Advanced Light Microscopy, Genentech Inc., South San Francisco, USA.; Department of Pathology, Genentech Inc., South San Francisco, USA., Scherl A; Department of Pathology, Genentech Inc., South San Francisco, USA., Ziai J; Department of Pathology, Genentech Inc., South San Francisco, USA., McNamara E; Department of In Vivo Pharmacology, Genentech Inc., South San Francisco, USA., Owyong M; Department of In Vivo Pharmacology, Genentech Inc., South San Francisco, USA., Rao S; Department of Oncology Bioinformatics, Genentech Inc., South San Francisco, USA., Calviello AK; Department of Oncology Bioinformatics, Genentech Inc., South San Francisco, USA., Oreper D; Department of Oncology Bioinformatics, Genentech Inc., South San Francisco, USA., Jhunjhunwala S; Department of Oncology Bioinformatics, Genentech Inc., South San Francisco, USA., Argiles G; Vall d'Hebrón Institute of Oncology, Vall d'Hebrón University Hospital, Universitat Autònoma de Barcelona, Barcelona, Spain., Bendell J; Sarah Cannon Research Institute/Tennessee Oncology, Nashville, TN, USA., Kim TW; Department of Oncology, Medical Center, University of Ulsan, Seoul, Korea., Ciardiello F; Department of Precision Medicine, Università degli Studi della Campania Luigi Vanvitelli, Naples, Italy., Wongchenko MJ; Oncology Biomarker Development, Genentech, Inc., South San Francisco, CA, USA., de Sauvage FJ; Department of Molecular Oncology, Genentech Inc., South San Francisco, USA., de Sousa E Melo F; Department of Discovery Oncology, Genentech Inc., South San Francisco, USA., Yan Y; Oncology Biomarker Development, Genentech, Inc., South San Francisco, CA, USA., West NR; Department of Cancer Immunology, Genentech Inc., South San Francisco, USA. west.nathaniel@gene.com., Murthy A; Department of Cancer Immunology, Genentech Inc., South San Francisco, USA. aditya.murthy@gilead.com.; Gilead Sciences, Foster City, USA. aditya.murthy@gilead.com.
Publikováno v:
Nature communications [Nat Commun] 2023 Sep 23; Vol. 14 (1), pp. 5945. Date of Electronic Publication: 2023 Sep 23.
Autor:
Shi Z; Department of Oncology Biomarker, Genentech Inc., South San Francisco, California., Wulfkuhle J; Center for Applied Proteomics and Molecular Medicine, George Mason University, Manassas, Virginia., Nowicka M; F. Hoffmann-La Roche Ltd, Basel, Switzerland., Gallagher RI; Center for Applied Proteomics and Molecular Medicine, George Mason University, Manassas, Virginia., Saura C; Medical Oncology Department, Vall d'Hebron University Hospital, Barcelona, Spain.; Breast Cancer Group, Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain.; SOLTI Breast Cancer Research Group, Barcelona, Spain., Nuciforo PG; Molecular Oncology Group, Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain., Calvo I; Breast Cancer Unit, Centro Integral Oncologico Clara Campal (CIOCC), Madrid, Spain., Andersen J; Medical Oncology/Hematology, Compass Oncology, Tigard, Oregon., Passos-Coelho JL; Oncology Department, Hospital Beatriz Angelo, Loures, Portugal., Gil-Gil MJ; SOLTI Breast Cancer Research Group, Barcelona, Spain.; Medical Oncology Service, Institut Català d'Oncologia, L'Hospitalet, Barcelona, Spain.; Institut d'Investigació Biomédica de Bellvitge (IDIBELL), Barcelona, Spain., Bermejo B; Hospital Clinico Universitario de Valencia, Valencia, Spain., Pratt DA; Texas Oncology Cancer Center, US Oncology, Austin, Texas., Ciruelos EM; SOLTI Breast Cancer Research Group, Barcelona, Spain.; Medical Oncology Department, University Hospital 12 de Octubre, Madrid, Spain., Villagrasa P; SOLTI Breast Cancer Research Group, Barcelona, Spain., Wongchenko MJ; Department of Oncology Biomarker, Genentech Inc., South San Francisco, California., Petricoin EF; Center for Applied Proteomics and Molecular Medicine, George Mason University, Manassas, Virginia., Oliveira M; Medical Oncology Department, Vall d'Hebron University Hospital, Barcelona, Spain.; Breast Cancer Group, Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain.; SOLTI Breast Cancer Research Group, Barcelona, Spain., Isakoff SJ; Division of Hematology/Oncology, Massachusetts General Hospital Cancer Center, Boston, Massachusetts.
Publikováno v:
Clinical cancer research : an official journal of the American Association for Cancer Research [Clin Cancer Res] 2022 Mar 01; Vol. 28 (5), pp. 993-1003.
Autor:
Turner N; Breast Unit, The Royal Marsden NHS Foundation Trust, Fulham Road, London, SW3 6JJ, UK. Nick.Turner@icr.ac.uk.; Breast Cancer Now Research Centre, The Institute of Cancer Research, London, UK. Nick.Turner@icr.ac.uk., Dent RA; Division of Medical Oncology, National Cancer Centre Singapore, Singapore, Singapore., O'Shaughnessy J; Department of Medical Oncology, Texas Oncology, Baylor University Medical Center, US Oncology, Dallas, TX, USA., Kim SB; Department of Oncology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, South Korea., Isakoff SJ; Division of Hematology and Oncology, Massachusetts General Hospital, Boston, MA, USA., Barrios C; Latin American Cooperative Oncology Group, Oncology Research Service, Hospital São Lucas, PUCRS, Porto Alegre, RS, Brazil., Saji S; Department of Medical Oncology, Fukushima Medical University Hospital, Fukushima, Japan., Bondarenko I; Oncology and Medical Radiology Department, City Clinical Hospital No. 4, Dnipropetrovsk, Ukraine., Nowecki Z; Oncology Centre, Instytut im. Marii-Sklodowskiej, Warsaw, Poland., Lian Q; Biostatistics, Genentech, Inc, South San Francisco, CA, USA., Reilly SJ; Pharma Development, Roche Products Ltd, Welwyn Garden City, UK., Hinton H; Product Development Safety, F. Hoffmann-La Roche Ltd, Basel, Switzerland., Wongchenko MJ; Oncology Biomarker Development, Genentech, Inc, South San Francisco, CA, USA., Kovic B; Patient-Centered Outcomes Research, Product Development, Hoffmann-La Roche Limited, Mississauga, ON, Canada., Mani A; Product Development Oncology, Genentech, Inc, South San Francisco, CA, USA., Oliveira M; Medical Oncology Department, Vall d'Hebron University Hospital, Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain.
Publikováno v:
Breast cancer research and treatment [Breast Cancer Res Treat] 2022 Feb; Vol. 191 (3), pp. 565-576. Date of Electronic Publication: 2021 Dec 03.
Autor:
Dent R; Division of Medical Oncology, National Cancer Centre Singapore, Singapore, Singapore. rebecca.dent@duke-nus.edu.sg.; Duke-NUS Medical School, 11 Hospital Crescent, Singapore, Singapore. rebecca.dent@duke-nus.edu.sg., Oliveira M; Medical Oncology Department, Vall d'Hebron University Hospital, Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain., Isakoff SJ; Division of Hematology and Oncology, Massachusetts General Hospital, Boston, MA, USA., Im SA; Department of Internal Medicine, Seoul National University Hospital, and Cancer Research Institute, Seoul National University College of Medicine, Seoul, Korea., Espié M; Department of Medical Oncology, Breast Disease Center, Hospital Saint Louis, Paris, France., Blau S; Oncology Division, Northwest Medical Specialties, Puyallup, WA, USA., Tan AR; Department of Solid Tumor and Investigational Therapeutics, Levine Cancer Institute, Atrium Health, Charlotte, NC, USA., Saura C; Medical Oncology Department, Vall d'Hebron University Hospital, Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain., Wongchenko MJ; Oncology Biomarker Development, Genentech, Inc., South San Francisco, CA, USA., Xu N; Biostatistics, Genentech, Inc., South San Francisco, CA, USA., Bradley D; Pharma Development, Roche Products Ltd, Welwyn Garden City, UK., Reilly SJ; Pharma Development, Roche Products Ltd, Welwyn Garden City, UK., Mani A; Product Development Oncology, Genentech, Inc., South San Francisco, CA, USA., Kim SB; Department of Oncology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, South Korea.
Publikováno v:
Breast cancer research and treatment [Breast Cancer Res Treat] 2021 Sep; Vol. 189 (2), pp. 377-386. Date of Electronic Publication: 2021 Jul 15.
Autor:
Sweeney C; Dana-Farber Cancer Institute, Boston, MA, USA., Bracarda S; Azienda Ospedaliera Santa Maria, Terni, Italy., Sternberg CN; Englander Institute for Precision Medicine, Weill Cornell Medicine, New York-Presbyterian, New York City, NY, USA., Chi KN; BC Cancer, Vancouver, BC, Canada., Olmos D; Spanish National Cancer Research Centre (CNIO), Madrid, Spain; Instituto de Investigación Biomédica de Málaga (IBIMA), Málaga, Spain., Sandhu S; Peter MacCallum Cancer Centre and University of Melbourne, Melbourne, VIC, Australia., Massard C; Institut Gustave Roussy, Villejuif, France., Matsubara N; National Cancer Center Hospital East, Chiba, Japan., Alekseev B; P A Herzen Moscow Oncology Research Institute, Moscow, Russia., Parnis F; Ashford Cancer Centre Research, Kurralta Park, SA, Australia., Atduev V; Volga District Medical Centre under Federal Medical and Biological Agency of Russia, Nizhny Novgorod, Russia., Buchschacher GL Jr; Kaiser Permanente Southern California, Los Angeles Medical Center, Los Angeles, CA, USA., Gafanov R; Russian Scientific Center of Roentgenology and Radiology, Moscow, Russia., Corrales L; Medical Oncology, Centro de Investigación y Manejo del Cáncer CIMCA, San José, Costa Rica., Borre M; Aarhus University Hospital, Aarhus, Denmark., Stroyakovskiy D; Moscow City Oncology Hospital Number 62 of Moscow Healthcare Department, Moscow Oblast, Russia., Alves GV; Centro Integrado de Pesquisa em Oncologia, Hospital Nossa Senhora da Conceição, Porto Alegre, Brazil., Bournakis E; Oncologic Clinical Trials and Research Clinic, Metropolitan General Hospital, Athens, Greece., Puente J; Medical Oncology Department, Hospital Clínico San Carlos, Instituto de Investigación Sanitaria del Hospital Clínico San Carlos (IdISSC), CIBERONC, Madrid, Spain., Harle-Yge ML; F Hoffmann-La Roche, Basel, Switzerland., Gallo J; F Hoffmann-La Roche, Basel, Switzerland., Chen G; Genentech, South San Francisco, CA, USA., Hanover J; Genentech, South San Francisco, CA, USA., Wongchenko MJ; Genentech, South San Francisco, CA, USA., Garcia J; F Hoffmann-La Roche, Basel, Switzerland., de Bono JS; Division of Clinical Studies, The Institute of Cancer Research, London, UK; Drug Development Unit, Royal Marsden Hospital, Sutton, UK. Electronic address: johann.de-bono@icr.ac.uk.
Publikováno v:
Lancet (London, England) [Lancet] 2021 Jul 10; Vol. 398 (10295), pp. 131-142.
Autor:
Daemen A; Department of Bioinformatics & Computational Biology, Genentech, Inc., South San Francisco, California. anneleen.daemen@oricpharma.com melissa.junttila@oricpharma.com., Cooper JE; Department of Molecular Oncology, Genentech, Inc., South San Francisco, California., Myrta S; Roche Global IT Solution Centre, Roche, Warsaw, Poland., Wongchenko MJ; Department of Oncology Biomarker Development, Genentech, Inc., South San Francisco, California., Lin E; Department of Molecular Oncology, Genentech, Inc., South San Francisco, California., Long JE; Department of Molecular Oncology, Genentech, Inc., South San Francisco, California., Foreman O; Department of Research Pathology, Genentech, Inc., South San Francisco, California., Modrusan Z; Department of Microchemistry, Proteomics and Lipidomics, Genentech, Inc., South San Francisco, California., Tremayne JR; Department of Translational Oncology, Genentech, Inc., South San Francisco, California., de la Cruz CC; Department of Translational Oncology, Genentech, Inc., South San Francisco, California., Merchant M; Department of Translational Oncology, Genentech, Inc., South San Francisco, California., Martin SE; Department of Molecular Oncology, Genentech, Inc., South San Francisco, California., Yan Y; Department of Oncology Biomarker Development, Genentech, Inc., South San Francisco, California., Junttila MR; Department of Molecular Oncology, Genentech, Inc., South San Francisco, California. anneleen.daemen@oricpharma.com melissa.junttila@oricpharma.com.
Publikováno v:
Clinical cancer research : an official journal of the American Association for Cancer Research [Clin Cancer Res] 2021 Feb 15; Vol. 27 (4), pp. 1162-1173. Date of Electronic Publication: 2020 Oct 06.
Autor:
Wongchenko MJ; Oncology Biomarker Development, Genentech, South San Francisco, CA., Kim SB; Department of Oncology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, South Korea., Saura C; Medical Oncology Department, Vall d'Hebron University Hospital, Vall d'Hebron Institute of Oncology, Barcelona, Spain., Oliveira M; Medical Oncology Department, Vall d'Hebron University Hospital, Vall d'Hebron Institute of Oncology, Barcelona, Spain., Lipson D; Foundation Medicine, Cambridge, MA., Kennedy M; Foundation Medicine, Cambridge, MA., Greene M; Foundation Medicine, Cambridge, MA., Breese V; Foundation Medicine, Cambridge, MA., Mani A; Product Development, Genentech, South San Francisco, CA., Xu N; Product Development Biostatistics, Genentech, South San Francisco, CA., Dent R; Division of Medical Oncology, National Cancer Centre, Singapore, Singapore.
Publikováno v:
JCO precision oncology [JCO Precis Oncol] 2020 Nov; Vol. 4, pp. 1012-1024.
Autor:
Ascierto PA; Melanoma Unit, Cancer Immunotherapy and Development Therapeutics, Istituto Nazionale Tumori IRCCS Fondazione G. Pascale, Naples, Italy. Electronic address: p.ascierto@istitutotumori.na.it., Lewis KD; Department of Medicine, University of Colorado Comprehensive Cancer Center, Aurora, Colorado, USA., Di Giacomo AM; Division of Medical Oncology and Immunotherapy, University Hospital of Siena, Siena, Italy., Demidov L; Department of Biotherapy, N. N. Blokhin Russian Cancer Research Center, Ministry of Health, Moscow, Russia., Mandalà M; Department of Oncology and Haematology, Papa Giovanni XXIII Cancer Center Hospital, Bergamo, Italy., Bondarenko I; Dnipropetrovsk State Medical Academy, Dnipropetrovsk, Ukraine., Herbert C; Bristol Haematology and Oncology Centre, University Hospitals Bristol NHS Foundation Trust, Bristol, UK., Mackiewicz A; Department of Cancer Immunology, Poznan University of Medical Sciences, Med-POLONIA, Poznan, Poland., Rutkowski P; Department of Soft Tissue/Bone Sarcoma and Melanoma, Maria Sklodowska-Curie Institute - Oncology Center, Warsaw, Poland., Guminski A; Melanoma Translational Research Group, Melanoma Institute Australia, Wollstonecraft, New South Wales, Australia., Simmons B; Product Development Oncology, Genentech, Inc., South San Francisco, California, USA., Ye C; Oncology Biostatistics, Genentech, Inc., South San Francisco, California, USA., Hooper G; Clinical Development Department, Roche Products Ltd., Welwyn Garden City, UK., Wongchenko MJ; Oncology Biomarker Development, Genentech, Inc., South San Francisco, California, USA., Goodman GR; Safety Science Oncology, Genentech, Inc., South San Francisco, California, USA., Yan Y; Oncology Biomarker Development, Genentech, Inc., South San Francisco, California, USA., Schadendorf D; Department of Dermatology, Essen University Hospital, Essen, Germany; German Cancer Consortium, Heidelberg, Germany.
Publikováno v:
Annals of oncology : official journal of the European Society for Medical Oncology [Ann Oncol] 2020 Jan; Vol. 31 (1), pp. 153-159.
Autor:
Long JE; Department of Translational Oncology, Genentech, Inc., 1 DNA Way, South San Francisco, CA, 94080, USA., Wongchenko MJ; Department of Oncology Biomarker Development, Genentech, Inc., 1 DNA Way, South San Francisco, CA, 94080, USA., Nickles D; Department of Bioinformatics and Computational Biology, Genentech, Inc., 1 DNA Way, South San Francisco, CA, 94080, USA., Chung WJ; Department of Bioinformatics and Computational Biology, Genentech, Inc., 1 DNA Way, South San Francisco, CA, 94080, USA.; 23andMe, 899 W Evelyn Ave, Mountain View, CA, 94041, USA., Wang BE; Department of Translational Oncology, Genentech, Inc., 1 DNA Way, South San Francisco, CA, 94080, USA., Riegler J; Department of Biomedical Imaging, Genentech, Inc., 1 DNA Way, South San Francisco, CA, 94080, USA., Li J; Department of Translational Oncology, Genentech, Inc., 1 DNA Way, South San Francisco, CA, 94080, USA., Li Q; Department of Microchemistry, Proteomics, & Lipidomics, Genentech, Inc., 1 DNA Way, South San Francisco, CA, 94080, USA., Sandoval W; Department of Microchemistry, Proteomics, & Lipidomics, Genentech, Inc., 1 DNA Way, South San Francisco, CA, 94080, USA., Eastham-Anderson J; Department of Pathology, Genentech, Inc., 1 DNA Way, South San Francisco, CA, 94080, USA., Modrusan Z; Department of Molecular Biology, Genentech, Inc., 1 DNA Way, South San Francisco, CA, 94080, USA., Junttila T; Department of Translational Oncology, Genentech, Inc., 1 DNA Way, South San Francisco, CA, 94080, USA., Carano RAD; Department of Biomedical Imaging, Genentech, Inc., 1 DNA Way, South San Francisco, CA, 94080, USA., Foreman O; Department of Pathology, Genentech, Inc., 1 DNA Way, South San Francisco, CA, 94080, USA., Yan Y; Department of Oncology Biomarker Development, Genentech, Inc., 1 DNA Way, South San Francisco, CA, 94080, USA., Junttila MR; Department of Translational Oncology, Genentech, Inc., 1 DNA Way, South San Francisco, CA, 94080, USA. junttila.melissa@gene.com.
Publikováno v:
Cell death and differentiation [Cell Death Differ] 2019 Nov; Vol. 26 (11), pp. 2416-2429. Date of Electronic Publication: 2019 Mar 01.